RAP (ASX) Sorry Rappers

Originally posted by RNClarke ↑

Sold out the last of my holdings this morning still trying to comprehend how these trials were so poorly conducted and at such a low standard which is beyond belief.

Management can blame the hospitals and the CRO who were running the trials all they like - but it is ultimately their ineptitude which has lead to this disaster. To top it all off we have found out Australian clinical trials have not been running to even the TGA's standard.

It is unbelievable that holders who had put their faith for 10+ months were given less than 30mins to digest top line data before ResApp opened from suspension. There was no rush to come out of voluntary suspension - Many screwed their exits.

Gutsy move by Chris N adding to his position. He was a Top 20 shareholder leading into results and had put his family money on the line.

The posters on here have turned over just like the register. Very sad for the entire Sydney ResApp faithful in particular @Red bar @pj had @Lefevre @yysy @whitehorse @gothechooks and any others I have missed. I am sure we will touch base at future events but not at any ResApp presentations. A learning curve for those of us who were hosed, plenty of other great stocks with products that actually work.

All the best.

Expand

"To top it all off we have found out Australian clinical trials have not been running to even the TGA's standard."

I think you're being very unfair with this comment. The Australian study was never a trial, and never purported to be one. Resapp has been completely open with the purpose of the study, which was to obtain training data and test the predictive capability of the algorithm once trained. Ditto for the Indonesian study.

If Resapp had conducted the trial here first with positive results, you'd be slamming the management for conducting the trials here where the population (and hence revenue base) of the entire country amounts to a single state in the USA.

You seem to be making investment decisions with your emotions. Sell at the best exit point you can see in the short term, and put your money where it will work for you. But I think that by writing off the product as well as the trial, you're boiling the baby in the bathwater!